Li Ping, Shu Hong-Jin, Wang Cunde, Mennerick Steven, Zorumski Charles F, Covey Douglas F, Steinbach Joe Henry, Akk Gustav
Department of Anesthesiology, Washington University School of Medicine, St Louis, MO 63110, USA.
J Physiol. 2007 Nov 1;584(Pt 3):789-800. doi: 10.1113/jphysiol.2007.142794. Epub 2007 Aug 30.
Neurosteroids are potent modulators of GABA-A receptors. We have examined the time course of development of potentiation of alpha1beta2gamma2L GABA-A receptors during coapplication of GABA and an endogenous neurosteroid (3alpha,5alpha)-3-hydroxypregnan-20-one (3alpha5alphaP). The simultaneous application of 3alpha5alphaP with 5 microm GABA resulted in a biphasic rising phase of current with time constants of 50-60 ms for the rapid phase and 0.3-3 s for the slow phase. The properties of the rapid phase were similar at all steroid concentrations but the time constant of the slower phase became successively shorter as the steroid concentration was increased. Potentiation developed very rapidly (tau = 130 ms) when cells were preincubated with 300 nm 3alpha5alphaP before application of GABA + 3alpha5alphaP, and in outside-out patch recordings, suggesting that steroid diffusion to intracellular compartments competes with receptor potentiation by depleting the cell membrane of steroid. Very low steroid concentrations (3-5 nm) potentiated GABA responses but the effects took minutes to develop. Intracellular accumulation of a fluorescent steroid analogue followed a similar time course, suggesting that slow potentiation results from slow accumulation within plasma membrane rather than indirect effects, such as activation of second messenger systems. In cell-attached single-channel recordings, where 3alpha5alphaP is normally applied through the pipette solution, addition of steroid to the bath solution dramatically shifted the steroid potentiation concentration-effect curve to lower steroid concentrations. We propose that bath-supplied steroid compensates for the diffusion of pipette-supplied steroid out of the patch to the rest of the cell membrane and/or intracellular compartments. The findings suggest that previous studies overestimate the minimum concentration of steroid capable of potentiating GABA actions at GABA-A receptors. The results have implications for the physiological role of endogenous neurosteroids.
神经甾体是γ-氨基丁酸A型(GABA-A)受体的强效调节剂。我们研究了在共同应用γ-氨基丁酸(GABA)和内源性神经甾体(3α,5α)-3-羟基孕烷-20-酮(3α5αP)期间,α1β2γ2L GABA-A受体增强作用的发育时间进程。3α5αP与5微摩尔GABA同时应用导致电流呈双相上升阶段,快速相的时间常数为50 - 60毫秒,慢速相的时间常数为0.3 - 3秒。在所有甾体浓度下,快速相的特性相似,但随着甾体浓度增加,慢速相的时间常数逐渐缩短。当在应用GABA + 3α5αP之前用300纳米3α5αP预孵育细胞时,增强作用发展非常迅速(时间常数τ = 130毫秒),并且在外侧膜片钳记录中也是如此,这表明甾体扩散到细胞内区室会通过耗尽细胞膜中的甾体而与受体增强作用竞争。非常低的甾体浓度(3 - 5纳米)可增强GABA反应,但这种作用需要数分钟才能显现。荧光甾体类似物的细胞内积累遵循相似的时间进程,这表明缓慢增强作用是由于质膜内的缓慢积累而非间接作用,如第二信使系统的激活。在细胞贴附式单通道记录中,通常通过微管溶液施加3α5αP,向浴液中添加甾体可显著将甾体增强作用的浓度 - 效应曲线向更低的甾体浓度方向移动。我们提出,浴液提供的甾体可补偿微管提供的甾体从膜片扩散到细胞膜其余部分和/或细胞内区室的损失。这些发现表明,先前的研究高估了能够增强GABA-A受体上GABA作用的甾体的最低浓度。这些结果对内源性神经甾体的生理作用具有重要意义。